Veracyte Inc at Morgan Stanley Global Healthcare Conference Transcript
Hello, everyone. Good afternoon. My name is Tejas Savant. I cover life science tools and diagnostics here at Morgan Stanley. It's my pleasure to host Veracyte this afternoon, and representing the company, we have Marc and Rebecca, CEO and CFO. It's great to have you both.
Before we dig into questions, quickly the research disclosures. Please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.
Questions & Answers
Right. So Marc, maybe just to start, you've been about a year in the hot seat now. What do you view as Veracyte's key accomplishments over the last 12 months? And what are you most excited about heading into '23?
Thanks, Tejas. Thanks for having us here today as well. Appreciate it. Before I dig
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |